LITFULO
LITFULO
Approved
DIN Number
02543532
Drug Class
Human
Market Date
Feb 13, 2024
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02543532
AIG Number0165362001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AF08 RITLECITINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification84:06.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
RITLECITINIB (RITLECITINIB TOSYLATE)Active
Strength: 50 MG
Monograph: RITLECITINIB (RITLECITINIB TOSYLATE)